CAPRA Annual Education Day 2025

Explore New Regulatory Insights at
HYBRID ANNUAL EDUCATION DAY  2025
Tuesday,  June 17, 2025  

Join us at the CAPRA Annual Education Day 2025 to hear from Health Canada and Industry on current hot topics of interest in Regulatory Affairs.

Register Now

 Hybrid Annual Education Day 2025 

CAPRA remains committed to educating and connecting our members. 

The Annual Education Day will be held on Tuesday, June 17, 2025, at the Pearson Convention Centre, Brampton ON.

This is an opportunity to hear from Health Canada and Industry on current hot topics of interest in regulatory affairs.

Topics will include:

  • How to reduce Labelling Clairfaxes (Non-Rx)
  • Health Canada and International Collaboration Initiatives (i.e., ORBIS, ACCESS and areas of collaboration such as the WHO reliance) 
  • National Strategy for Drugs for Rare Diseases  (Health Canada perspective) 
  • Rare Diseases: Regulatory landscape and market access (Industry speaker)
  • New Substances Notifications (NSN) for Cell and Gene Therapy Organisms 
  • Enhancing Regulatory Through Artificial Intelligence (AI) Innovations  
  • DEL Developments: Where We Stand and What's Next

See you soon. 

CAPRA Education Day Committee


Annual Education Day Speakers
Click on the speakers' picture to view their bio.

Ravneet Kaur

Ravneet Kaur 

Health Canada

MPharm,Senior Regulatory Affairs Officer, NNHPD

Dr. Maxime Sasseville

Dr. Maxime Sasseville

Health Canada

Manager, Oncology Division 2, PDD

Jennifer Grandy

Jennifer Grandy

Health Canada

Director, Governance and Bilateral Agreements, Office of Pharmaceuticals ManagementStrategies

Oxana Iliach

Oxana Iliach

Certara

Senior Director Regulatory Strategy

Catherine Sullivan

Catherine Sullivan

Health Canada

Regulatory Affairs Specialist, New Substances Assessment and Control Bureau

Doris Simcich

Doris Simcich

AstraZeneca

Global Senior Director Operational Excellence

Betsy Luo

Betsy Luo

AstraZeneca

R&D IT Business Analyst

Brian Randall

Brian Randall

Innomar Strategies Inc. (a division of Cencora) 

Director Quality Assurance

 

TimeTopic Guest SpeakerDuration
8:00 - 9:00 amRegistration, Networking  and Breakfast 60 mins
9:00 - 9:15 amWelcoming Remarks 15 mins
9:15 - 10:00 am

How to Reduce Labelling Clarifaxes

 

 

 

 


Ravneet Kaur,
MPharm, Senior Regulatory Affairs Officer, NNHPD,
 Health Canada 
Followed by Questions and Answers 

45 mins
10:00 - 10:40 am

Health Canada and International Collaboration Initiatives (i.e., ORBIS, ACCESS, etc.)

 

Dr. Maxime Sasseville,
Manager, Oncology Division 2, PDD, Health Canada
Followed by Questions and Answers

 

40 mins
10:40 - 11:00 amCoffee Break, Networking and Visit Vendor Booths 20 mins
11:00 - 11:40 am

 National Strategy for Drugs for Rare Diseases 

 

Jennifer Grandy,
Director, Governance and Bilateral Agreements, Office of Pharmaceuticals Management Strategies, Health Canada
Followed by Questions and Answers

 

40 mins
11:40 - 12:20 pmRare Diseases: Regulatory landscape and market access

 

 

Oxana Iliach,
Senior Director Regulatory Strategy, Certara
Followed by Questions and Answers

 

40 mins
12:20 - 1:20 pmLunch Break, Networking and Visit Vendor Booths 60 mins
1:20 - 2:00 pm

New Substances Notifications (NSN) for Cell and Gene

Therapy Organisms 

 

 

 

 

Catherine Sullivan,
Regulatory Affairs Specialist, New Substances Assessment and Control Bureau, Health Canada
Followed by Questions and Answers

 

40 mins
2:00 - 2:40 pm

Enhancing Regulatory Through Artificial Intelligence (AI) Innovations

 


Doris Simcich,
Global Senior Director Operational Excellence, AstraZeneca
 
Betsy Luo,
R&D IT Business Analyst, AstraZeneca
Followed by Questions and Answers

 

40 mins
2:40 - 3:00 pm

Coffee Break, Networking and Visit Vendor Booths

 


20 mins
3:00 - 3:40 pm

DEL Developments: Where We Stand and What’s Next? 

 


Brian Randall,

Director Quality Assurance, Innomar Strategies Inc. (a division of Cencora) 
Followed by Questions and Answers

 

40 mins
3:40 - 4:00 pmClosing Remarks
 CAPRA Education Day Committee20 mins
TimeDescription
8:00 - 9:00 amRegistration, Networking and Breakfast
9:00 - 9:15 amWelcoming Remarks
9:15 - 10:00 am

Topic: How to Reduce Labelling Clarifaxes

 

 

Health Canada (HC) Speaker: Ravneet Kaur, MPharm, Senior Regulatory Affairs Officer,

NNHPD 

followed by Questions and Answers

10:00 - 10:40 am   

Topic: Health Canada and International Collaboration Initiatives (i.e., ORBIS, ACCESS, etc.)

 

 

Health Canda (HC) Speaker: Dr. Maxime Sasseville, Manager, Oncology Division 2, PDD 

followed by Questions and Answers

 

10:40 - 11:00 am

Coffee Break, Networking and Visit Vendor Booths

11:00 - 11:40 am

Topic: National Strategy for Drugs for Rare Diseases   
Health Canada (HC) Speaker: Jennifer Grandy, Director, Governance and Bilateral Agreements, Office of Pharmaceuticals Management Strategies 
followed by Questions and Answers

11:40 - 12:20 pmTopic:Rare Diseases: Regulatory landscape and market access

Industry Speaker: Oxana Iliach, Senior Director Regulatory Strategy, Certara

followed by Questions and Answers

12:20 - 1:20 pm

Lunch Break, Networking and Visit Vendir Booths

1:20 - 2:00 pm

Topic: New Substances Notifications (NSN) for Cell and Gene Therapy Organisms

 

 

Health Canada (HC) Speaker: Catherine Sullivan, Regulatory Affairs Specialist, New

Substances Assessment and Control Bureau 

 

followed by Questions and Answers

2:00 - 2:40 pm

Topic: Enhancing Regulatory Through Artificial Intelligence (AI) Innovations   
Industry Speaker: Doris Simcich, Global Senior Director Operational Excellence, AstraZeneca 
Industry Speaker:  Betsy Luo, R&D IT Business Analyst, AstraZeneca
followed by Questions and Answers

2:40 - 3:00 pm Coffee Break, Networking and Visit Vendor Booths
3:00 - 3:40 pm

Topic: DEL Developments: Where We Stand and What’s Next? 

Industry Speaker: Brian Randall, Director Quality Assurance, Innomar Strategies Inc. (a

division of Cencora) 

followed by Questions and Answers 

 

 

 

 

3:40 - 4:00 pmClosing Remarks
CAPRA Education Day Committee

Registration & Tickets
(HST will be added at time of checkout)
Registration Deadline: June 10, 2025

CategoryIn-Person AttendanceOnline Access
CAPRA Members$500$400
Non-Members$600$500
CAPRA Student Members$275$275

IMPORTANT DEADLINES

DeadlineDate
Registration DeadlineJune 10, 2025

 Our sponsorship and vendor packages include registration tickets.

For further assistance, please contact CAPRA at administrator@capra.ca.


Thank You to Our Sponsors

We extend our sincere gratitude to the generous sponsors of CAPRA Education Day 2025. Your commitment plays a crucial role in bringing together leading experts in Pharmaceuticals and Regulatory Affairs, fostering collaboration, and driving industry innovation.  Your support helps ensure the success of this vital knowledge-sharing platform, empowering professionals to exchange insights, explore new developments, and shape the future of Regulatory Affairs.

Thank you for being an integral part of this event and for your continued dedication to advancing the industry!

Click on our sponsors' logos to view more resources.

Sponsorship & Vendor Booth Opportunities

For any questions you may have, please email administrator@capra.ca.

HST will be added at the time of checkout.

Platinum Sponsor

Platinum Sponsorship
$2,300

Benefits:

  • Booth, Two (2) attendee tickets
  • Company logo and hyperlink on all event media broadcasts and the CAPRA event webpage
  • Promotion of the company logo before and during the event
  • One page of digital collateral material sent to all attendees by the event host
  • excludes HST 
Gold Sponsor

Gold Sponsorship
$1,920

Benefits:

  • Booth, Two (2) attendee tickets
  • Company logo and hyperlink on all event media broadcasts and the CAPRA event webpage
  • excludes HST
Vendor Booth

Vendor Booth Options
$1,620 | $1,010

Benefits

  • Booth, Two (2) attendee passes: $1,620 
    excludes HST
  • Booth, One (1) attendee passes: $1,010
    excludes HST